Skip to content
Play Video
Who we are

Nuturing a safe, legal and flourishing consumer cannabis extract market

The Association for the Cannabinoid Industry (ACI) is a membership organisation for businesses committed to nurturing a safe, legal and flourishing consumer cannabis extract market in the UK and Europe.

The UK has the world’s most developed regulatory framework for legal cannabinoids. This market is estimated to be worth £690 million ($1 billion) in 2021, making it the second largest in the world after the US.

What we do

Securing regulatory compliance for our members

Toxicological Data

Cost-effective access to toxicological data required to gain novel foods authorisation from FSA (UK) and EFSA (EU).

Representation

We represent our members at the highest level so their voice is heard and a favourable regulatory environment exists.

Technical Consultancy

Our team of industry experts offer bespoke consultancy solutions to support our members.

Food Standards Authority Novel Foods

We have successfully assisted brands in their continued authorisation for sale within the UK

As of 31 March 2022, the UK has become the first country in the world to apply regulation to products containing CBD through the Food Standards Agency (FSA) Novel Foods authorisation process. 69% of all applications on the FSA’s public list can be linked to ACI’s CBD safety consortium. 100% of ACI member applications successfully appeared on this list.

As the leading trade body for the cannabinoid industry we are here to help your business in its next steps within this rapidly growing market. To find out more, contact us via the button below, or call us on 0800 310 10 54.

Membership

Our membership offering

ACI helped 100% of our members get on the FSA’s public list of CBD products permitted to be sold in the UK. In fact, 69% of all applications on the FSA’s list are linked to ACI’s CBD safety consortium. 

If you are facing challenges meeting the FSA’s requirements to legally sell cannabinoid extracts in the UK the ACI can help.

We offer our members

  • – Representation – We represent our members at the highest level so their voice is heard and a favourable regulatory environment exists  
  • – Data – Cost-effective access to toxicological data required to gain novel foods authorisation from FSA (UK) and EFSA (EU)
  • – Technical consultancy – Our team of industry experts offer bespoke consultancy solutions to support our members

If you are already established or looking to enter the UK’s legal cannabinoid market ACI membership can benefit you.

ACI offers solutions for raw material suppliers, manufacturers, brands, retailers and others operating in this space.

Industry Representation
Toxicological Data
Industry Expertise
Trading Standards Partnership
Networking Opportunities
News

Latest ACI related news & statements

ACI Respond to NPA Statement in CBD Regulation

Steve Moore, ACI Strategic Counsel has today responded to the National Pharmacy Association’s advisory statement regarding CBD products in pharmacies with the following statement:
Our team

Meet the ACI team